Literature DB >> 15452030

Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the lyon hypertensive rat.

Marijo Bilusic1, Alain Bataillard, Michael R Tschannen, Li Gao, Nadia E Barreto, Madeleine Vincent, Tao Wang, Howard J Jacob, Jean Sassard, Anne E Kwitek.   

Abstract

The complex nature of hypertension makes identifying the pathophysiology and its genetic contributions a challenging task. One powerful approach for the genetic dissection of blood pressure regulation is studying inbred rat models of hypertension, as they provide natural allele variants but reduced heterogeneity (both genetic and etiologic). Furthermore, the detailed physiologic studies to which the rat is amenable allow for the determination of intermediate phenotypes. We have performed a total genome scan in offspring of an F2 intercross between the Lyon hypertensive (LH) and Lyon normotensive rat strains to identify linkage of anthropometric, blood pressure, renal, metabolic, and endocrine phenotypes. Quantitative trait locus (QTL) regions involved in blood pressure regulation, end-stage organ damage, body and organ weight, and lipid metabolism in the LH rat were identified on chromosomes 1, 2, 3, 5, 7, 10, 13, and 17, with 2 phenotypes associated with the metabolic syndrome identified on chromosomes 1 and 17. Regions on chromosomes 2, 13, and 17 were revealed to be important for blood pressure regulation. Regions on chromosome 17 were found to significantly contribute to both metabolic homeostasis and blood pressure regulation; 2 aggregates of a total of 23 QTLs were identified, including several "intermediate phenotypes." These intermediate phenotypes may be used as closer surrogates to the mechanisms leading to hypertension and metabolic dysfunction in the LH rat.

Entities:  

Mesh:

Year:  2004        PMID: 15452030     DOI: 10.1161/01.HYP.0000144542.57306.5e

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Rat chromosome 8 confers protection against dyslipidemia caused by a high-fat/low-carbohydrate diet.

Authors:  Leah C Solberg Woods; Brett C Woods; Caroline M Leitschuh; Sonia J Laurie; Howard J Jacob
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-06-19

2.  Rat Models of Metabolic Syndrome.

Authors:  Anne E Kwitek
Journal:  Methods Mol Biol       Date:  2019

3.  Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations.

Authors:  Detlef Bockenhauer; Sally Feather; Horia C Stanescu; Sascha Bandulik; Anselm A Zdebik; Markus Reichold; Jonathan Tobin; Evelyn Lieberer; Christina Sterner; Guida Landoure; Ruchi Arora; Tony Sirimanna; Dorothy Thompson; J Helen Cross; William van't Hoff; Omar Al Masri; Kjell Tullus; Stella Yeung; Yair Anikster; Enriko Klootwijk; Mike Hubank; Michael J Dillon; Dirk Heitzmann; Mauricio Arcos-Burgos; Mark A Knepper; Angus Dobbie; William A Gahl; Richard Warth; Eamonn Sheridan; Robert Kleta
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

Review 4.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

5.  Distinct QTLs are linked to cardiac left ventricular mass in a sex-specific manner in a normotensive inbred rat inter-cross.

Authors:  Bastien Llamas; Zhibin Jiang; Marie-Line Rainville; Sylvie Picard; Christian F Deschepper
Journal:  Mamm Genome       Date:  2005-10-20       Impact factor: 2.957

6.  Strain survey and genetic analysis of vasoreactivity in mouse aorta.

Authors:  Seung Kyum Kim; Joshua J Avila; Michael P Massett
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

7.  Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.

Authors:  Kumar Kotlo; Sumit Bhattacharyya; Bo Yang; Leonid Feferman; Shah Tejaskumar; Robert Linhardt; Robert Danziger; Joanne K Tobacman
Journal:  Glycoconj J       Date:  2013-02-06       Impact factor: 2.916

8.  Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.

Authors:  Maria Regina Freitas; Masumi Eto; Jason A Kirkbride; Christa Schott; Jean Sassard; Jean-Claude Stoclet
Journal:  Fundam Clin Pharmacol       Date:  2009-03-09       Impact factor: 2.748

Review 9.  Opportunities and limitations of genetic analysis of hypertensive rat strains.

Authors:  Juan M Saavedra
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

10.  Quantitative trait loci for urinary albumin in crosses between C57BL/6J and A/J inbred mice in the presence and absence of Apoe.

Authors:  Carolien Doorenbos; Shirng-Wern Tsaih; Susan Sheehan; Naoki Ishimori; Gerjan Navis; Gary Churchill; Keith Dipetrillo; Ron Korstanje
Journal:  Genetics       Date:  2008-05       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.